TPN-101 in Aicardi-Goutières Syndrome (AGS)

Clinical trial NCT05613868 · TERMINATED

Trial details

NCT number: NCT05613868
Sponsor: Transposon Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Aicardi-Goutières Syndrome (AGS)

Start date: 2023-03-15
Primary completion: 2025-02-27
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.